3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Solid Tumors
1
Renal Pelvis and Ureter Urothelial Carcinoma
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Lymphoma, T-Cell
1
Leukemia, Plasma Cell
1
Leukemia, Myeloid, Acute
1
Leukemia, Monocytic, Acute
1
Hodgkin Disease
1
Burkitt Lymphoma
1
Adenocarcinoma, Bronchiolo-Alveolar
1
Adenocarcinoma of Lung
1
Interventions
X-Rays
6
Phantoms, Imaging
6
Magnetic Resonance Spectroscopy
6
Specimen Handling
5
Nuclear Medicine Department, Hospital
5
Biopsy
4
ulixertinib
2
tipifarnib
2
selpercatinib
2
larotrectinib
2
ivosidenib
2
erdafitinib
2
ensartinib
2
Cyclophosphamide
2
tazemetostat
1
talazoparib
1
selinexor
1
palbociclib
1
olaparib
1
irinotecan sucrosofate
1
fludarabine phosphate
1
fludarabine
1
atezolizumab
1
Vincristine
1
Vinblastine
1
Vemurafenib
1
Topotecan
1
Tiragolumab
1
Temozolomide
1
Pharmacogenomic Variants
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Rhabdoid Tumor
×
pegylated granulocyte colony-stimulating factor
×
30 days
×
Clear all
No trials found.